시장보고서
상품코드
1268539

세계의 보툴리눔톡신(보톡스) 시장(2023-2032)

Global Botulinum Toxin Market Forecast 2023-2032

발행일: | 리서치사: Inkwood Research | 페이지 정보: 영문 233 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 보툴리눔톡신(보톡스) 시장 규모는 2023년부터 2032년까지의 예측 기간 동안 10.07%의 CAGR을 나타낼 것으로 예상됩니다. 미용 시술에 대한 수요 급증, 노인 인구 증가, 비침습적 미용 시술에 대한 수요 증가가 시장 성장을 가속하고 있습니다.

이 보고서는 세계 보툴리눔 독소(Botulinum Toxin) 시장을 조사하여 시장 역학, 시장 분석, 경쟁 상황 등의 종합적인 정보를 제공합니다.

목차

제1장 조사 범위와 조사 방법

  • 조사 목적
  • 조사 방법
  • 전제와 제한

제2장 주요 요약

  • 시장 규모와 추정
  • 시장 개요
  • 조사 범위
  • 위기 시나리오 분석
    • 보툴리눔톡신(보톡스) 시장에 대한 COVID-19의 영향
  • 주요 시장 조사 결과
    • 시장 성장에 기여하는 유리한 규제 인가
    • 'NOTOX'에 대한 인식 증가
    • 성형관광 확대가 보툴리눔톡신(보톡스) 수요를 증가

제3장 시장 역학

  • 주요 촉진요인
    • 미용 시술에 대한 수요 급증
    • 고령자 인구 증가
    • 비침습적인 미용 시술에 대한 수요 증가
  • 주요 억제요인
    • 보툴리눔톡신(보톡스)의 악영향에 관한 우려
    • 미용 시술을 지원하는 상환 정책 부족

제4장 주요 분석

  • 주요 시장 동향
  • Porter's Five Forces 분석
    • 바이어의 힘
    • 공급업체의 힘
    • 대체품
    • 신규 진출기업
    • 산업 경쟁
  • 성장 전망 매핑
    • 미국의 성장 전망 매핑
    • 독일의 성장 전망 매핑
    • 중국의 성장 전망 매핑
    • 브라질의 성장 전망 매핑
  • 시장 성숙도 분석
  • 시장 집중 분석

제5장 시장 : 유형별

  • A형 보툴리눔톡신(보톡스)
  • B형 보툴리눔톡신(보톡스)

제6장 시장 : 사용자별

  • 여성
  • 남성

제7장 시장 : 용도별

  • 의학
    • 만성 편두통
    • 근육 경련
    • 과민성 방광
    • 다한증
    • 기타 의료 용도
  • 미용
    • 눈주름
    • 이마 라인
    • 미간 주름/미간
    • 사각턱/광대
    • 기타 미용 용도

제8장 시장 : 최종사용자별

  • 전문 및 피부과 클리닉
  • 병원 및 클리닉
  • 기타 최종사용자

제9장 지역 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 세계 기타 지역

제10장 경쟁 구도

  • 주요 전략적 전개
    • 인수
    • 제품 발매와 개발
    • 파트너십
    • 사업 확대
  • 기업 개요
    • ABBVIE
    • CANDELA MEDICAL
    • DAEWOONG PHARMACEUTICAL CO LTD
    • EVOLUS INC
    • GALDERMA
    • HUGEL INC
    • IPSEN
    • LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
    • MEDYTOX INC
    • MERZ PHARMA
    • REVANCE THERAPEUTICS INC
    • US WORLDMEDS LLC
LSH 23.05.16

KEY FINDINGS

The global botulinum toxin market is predicted to record a 10.07% CAGR during the forecast period, 2023-2032. The surge in demand for aesthetic procedures, the rising geriatric population, and the demand for non-invasive cosmetic procedures driving the botulinum toxin market drive the market growth.

MARKET INSIGHTS

Botulinum toxin is a neurotoxin produced by certain Clostridium botulinum strains and is utilized for both therapeutic and cosmetic purposes. Its cosmetic form, commonly referred to as Botox by patients, is an injectable that temporarily reduces or eliminates wrinkles and fine lines on the face. The most frequently treated areas include frown lines, forehead wrinkles, and crow's feet around the eyes, but it is also used to treat other areas such as gummy smiles, lip lines, overactive jaw muscles, and thick neck bands.

Several factors, including increasing demand for aesthetic procedures, growth in non-invasive cosmetic procedures, research and development initiatives, and a rise in the geriatric population, are propelling the global market for botulinum toxin. With an increasing number of people worldwide undergoing aesthetic procedures each year, the market for botulinum toxin is expected to experience significant growth in the coming years.

REGIONAL INSIGHTS

The global botulinum toxin market analysis comprises a study of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to dominate the market due to the growing R&D efforts to broaden therapeutic uses and an increase in cosmetic issues like crow's feet and medial canthal wrinkles. Additionally, factors such as disposable personal income and per capita disposable income in the United States are expected to fuel the growth of the botulinum toxin market in North America.

COMPETITIVE INSIGHTS

Market players invest in R&D, label extension, and acquisitions to enhance product offerings. Innovation, advertising, competitive strategies, and high concentration ratio increase industry rivalry.

Major market players include Medytox, Merz Pharma, Lanzhou Institute of Biological Products Co Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW
  • 2.3. SCOPE OF STUDY
  • 2.4. CRISIS SCENARIO ANALYSIS
    • 2.4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
  • 2.5. MAJOR MARKET FINDINGS
    • 2.5.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
    • 2.5.2. GROWING AWARENESS ABOUT 'NOTOX'
    • 2.5.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
    • 3.1.2. RISING GERIATRIC POPULATION
    • 3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
    • 3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES

4. KEY ANALYTICS

  • 4.1. KEY MARKET TRENDS
  • 4.2. PORTER'S FIVE FORCES ANALYSIS
    • 4.2.1. BUYERS POWER
    • 4.2.2. SUPPLIERS POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. GROWTH PROSPECT MAPPING
    • 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    • 4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
    • 4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
    • 4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
  • 4.4. MARKET MATURITY ANALYSIS
  • 4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TYPE

  • 5.1. TYPE A BOTULINUM TOXIN
  • 5.2. TYPE B BOTULINUM TOXIN

6. MARKET BY USER DEMOGRAPHIC

  • 6.1. WOMEN
  • 6.2. MEN

7. MARKET BY APPLICATION

  • 7.1. MEDICAL
    • 7.1.1. CHRONIC MIGRAINE
    • 7.1.2. MUSCLE SPASM
    • 7.1.3. OVERACTIVE BLADDER
    • 7.1.4. HYPERHIDROSIS
    • 7.1.5. OTHER MEDICAL APPLICATIONS
  • 7.2. AESTHETIC
    • 7.2.1. CROW'S FEET
    • 7.2.2. FOREHEAD LINES
    • 7.2.3. FROWN LINES/GLABELLAR
    • 7.2.4. SQUARE JAW/MASSETER
    • 7.2.5. OTHER AESTHETIC APPLICATIONS

8. MARKET BY END-USER

  • 8.1. SPECIALTY AND DERMATOLOGY CLINICS
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
    • 9.1.3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
    • 9.1.4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.1.5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
    • 9.1.6. COUNTRY ANALYSIS
      • 9.1.6.1. UNITED STATES
      • 9.1.6.1.1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.1.6.2. CANADA
      • 9.1.6.2.1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
    • 9.2.3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
    • 9.2.4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.2.5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
    • 9.2.6. COUNTRY ANALYSIS
      • 9.2.6.1. UNITED KINGDOM
      • 9.2.6.1.1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.2. GERMANY
      • 9.2.6.2.1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.3. FRANCE
      • 9.2.6.3.1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.4. ITALY
      • 9.2.6.4.1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.5. SPAIN
      • 9.2.6.5.1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.6. NORDIC COUNTRIES
      • 9.2.6.6.1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.7. POLAND
      • 9.2.6.7.1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.2.6.8. REST OF EUROPE
      • 9.2.6.8.1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
    • 9.3.3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
    • 9.3.4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
    • 9.3.5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
    • 9.3.6. COUNTRY ANALYSIS
      • 9.3.6.1. CHINA
      • 9.3.6.1.1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.2. JAPAN
      • 9.3.6.2.1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.3. INDIA
      • 9.3.6.3.1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.4. SOUTH KOREA
      • 9.3.6.4.1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.5. SINGAPORE
      • 9.3.6.5.1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.6. THAILAND
      • 9.3.6.6.1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.7. AUSTRALIA & NEW ZEALAND
      • 9.3.6.7.1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.3.6.8. REST OF ASIA-PACIFIC
      • 9.3.6.8.1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
    • 9.4.3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
    • 9.4.4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
    • 9.4.5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
    • 9.4.6. REGIONAL ANALYSIS
      • 9.4.6.1. LATIN AMERICA
      • 9.4.6.1.1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
      • 9.4.6.2. MIDDLE EAST & AFRICA
      • 9.4.6.2.1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS
    • 10.1.4. BUSINESS EXPANSIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBVIE
      • 10.2.1.1. COMPANY OVERVIEW
      • 10.2.1.2. PRODUCT LIST
      • 10.2.1.3. STRENGTHS & CHALLENGES
    • 10.2.2. CANDELA MEDICAL
      • 10.2.2.1. COMPANY OVERVIEW
      • 10.2.2.2. PRODUCT LIST
      • 10.2.2.3. STRENGTHS & CHALLENGES
    • 10.2.3. DAEWOONG PHARMACEUTICAL CO LTD
      • 10.2.3.1. COMPANY PROFILE
      • 10.2.3.2. PRODUCT LIST
      • 10.2.3.3. STRENGTHS & CHALLENGES
    • 10.2.4. EVOLUS INC
      • 10.2.4.1. COMPANY OVERVIEW
      • 10.2.4.2. PRODUCT LIST
      • 10.2.4.3. STRENGTHS & CHALLENGES
    • 10.2.5. GALDERMA
      • 10.2.5.1. COMPANY OVERVIEW
      • 10.2.5.2. PRODUCT LIST
      • 10.2.5.3. STRENGTHS & CHALLENGES
    • 10.2.6. HUGEL INC
      • 10.2.6.1. COMPANY OVERVIEW
      • 10.2.6.2. PRODUCT LIST
      • 10.2.6.3. STRENGTHS & CHALLENGES
    • 10.2.7. IPSEN
      • 10.2.7.1. COMPANY OVERVIEW
      • 10.2.7.2. PRODUCTS / SERVICES LIST
      • 10.2.7.3. STRENGTHS & CHALLENGES
    • 10.2.8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
      • 10.2.8.1. COMPANY OVERVIEW
      • 10.2.8.2. PRODUCT LIST
      • 10.2.8.3. STRENGTHS & CHALLENGES
    • 10.2.9. MEDYTOX INC
      • 10.2.9.1. COMPANY OVERVIEW
      • 10.2.9.2. PRODUCT LIST
      • 10.2.9.3. STRENGTHS & CHALLENGES
    • 10.2.10. MERZ PHARMA
      • 10.2.10.1. COMPANY OVERVIEW
      • 10.2.10.2. PRODUCT LIST
      • 10.2.10.3. STRENGTHS & CHALLENGES
    • 10.2.11. REVANCE THERAPEUTICS INC
      • 10.2.11.1. COMPANY OVERVIEW
      • 10.2.11.2. PRODUCT LIST
    • 10.2.12. US WORLDMEDS LLC
      • 10.2.12.1. COMPANY OVERVIEW
      • 10.2.12.2. PRODUCT LIST
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제